Loading...
By Joe Elia
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
The continued use of beta-blockers 1 year after an acute myocardial infarction doesn't improve survival in some patients, a study in The BMJ finds.
Researchers prospectively followed some 2700 French patients who had acute MIs without heart failure or left-ventricular dysfunction.
Researchers compared patients not receiving beta-blockers to those receiving them early (within 48 hours of admission), those who were prescribed (or continued to take) the drugs at hospital discharge, and those still taking them at the 1-year mark.
Early-takers showed lower 30-day mortality (2.3%) than non-takers (8.6%). Mortality at 1 year was nonsignificantly lower among drug-takers (3.4%) versus non-takers (7.8%). Continued use at 1 year showed no survival advantage at the 5-year mark.
The authors conclude that their findings “suggest a progressively decreasing benefit of beta-blocker treatment over time.”
Comment
LINK(S):
The BMJ article (Free)
Background: NEJM Journal Watch Emergency Medicine coverage of early beta-blocker administration after STEMI (Your NEJM Journal Watch registration required)